Safety check: does new blood disorder drug mix safely with common meds?
NCT ID NCT06813924
Summary
This study tested whether a new drug called etavopivat, being developed for sickle cell disease and thalassemia, changes how the body processes five common medications. Thirty-seven healthy volunteers took etavopivat along with single doses of drugs like metformin, a statin, and a sedative. The goal was to measure drug levels in the blood to see if etavopivat makes these other medicines stronger, weaker, or stay in the body longer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS SICKLE CELL DISEASE, THALASSEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON-Salt Lake City
Salt Lake City, Utah, 84124, United States
Conditions
Explore the condition pages connected to this study.